Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals Leave a Comment / MAGAZINES / / July 3, 2021 / covaxin, Covaxin of Bharat Biotech, COVAXIN THIRD PHASE TRIAL, COVID vaccine
Aarogya Setu rolls out new feature to update Vaccination Status Leave a Comment / TC / CS SURBHI SAXENA / June 1, 2021 / aarogya setu app, covaxin, COVID, covid vaccination, COVID-19, COVISHIELD, COWIN, Partially Vaccinated, Self assessment, Vaccinated
Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha Leave a Comment / TC / CS SURBHI SAXENA / May 15, 2021 / atma nirbhar bharat, bharat biotech limited, covaxin, COVID, COVID-19, department of biotechnology, grant from government of india, mission covid suraksha
DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years Leave a Comment / TC / CS SURBHI SAXENA / May 13, 2021 / age group 2 to 18 years, Bharat Biotech ltd, covaxin, COVID, COVID vaccine, COVID-19
Bharat Biotech to sell Covaxin at Rs 600 to States, Rs 1200 to private hospitals Leave a Comment / TC / CS SURBHI SAXENA / April 25, 2021 / covaxin, Covaxin of Bharat Biotech, COVID-19, COVID-19 VACCINE
PM Modi interacted with Chief Ministers of all states Leave a Comment / TC / CS SURBHI SAXENA / January 12, 2021 / covaxin
DCGI clears Covid-19 vaccines Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin for restricted use in emergency Leave a Comment / TC / CS SURBHI SAXENA / January 4, 2021 / covaxin
India’s indigenous coronavirus vaccine ‘Covaxin’ shows no serious adverse effects in people in its 1st phase clinical trials Leave a Comment / TC / CS SURBHI SAXENA / December 18, 2020 / covaxin, COVID-19 VACCINE
